Nexera

Nxera Pharma is a technology-powered commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing specialty medicines for patients in Japan and globally. The company combines a Japan/APAC commercial business with a GPCR-focused discovery engine built around its proprietary NxWave platform for structure-based drug design. Its internal and partnered pipeline spans neurology, neuropsychiatry, immunology and inflammation, gastrointestinal disease, and metabolic disorders, with programs ranging from discovery through late-stage clinical development. Nxera also markets launched products in Japan and APAC and has collaborations with major pharmaceutical companies to advance GPCR-targeted small-molecule medicines.